PhD CandidateOregon Health & Science UniversityPortland, Oregon, United States
OC 49.2 - Pharmacological targeting of the contact pathway attenuates experimental autoimmune encephalomyelitis in mice
Monday, June 26, 202315:00 – 15:15 ET
PB0566 - Prediction and validation of the effects of targeting either coagulation FXI activation or activity on thrombin generation
Monday, June 26, 202318:30 – 19:30 ET
PB0700 - FXI inhibitor safety in hemophilia patients: computational prediction of thrombin generation.
